Safety evaluation of high‐dose intake of casein‐derived peptide Met‐Lys‐Pro in healthy adults: A randomized, double‐blind, placebo‐controlled trial

Met‐Lys‐Pro (MKP) is a casein‐derived angiotensin I‐converting enzyme inhibitory peptide with the potential to cross the blood–brain barrier. It has shown preventive effects against high blood pressure (BP) and cognitive decline in animal models and human studies. MKP shows good water solubility and...

Descripción completa

Detalles Bibliográficos
Autores principales: Yuda, Naoki, Tanaka, Miyuki, Tokushima, Masahiko, Abe, Fumiaki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7866589/
https://www.ncbi.nlm.nih.gov/pubmed/33598151
http://dx.doi.org/10.1002/fsn3.2028

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7866589/
https://www.ncbi.nlm.nih.gov/pubmed/33598151
http://dx.doi.org/10.1002/fsn3.2028

Ejemplares similares